Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11505616 Binding molecules to CD38 and PD-L1
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Current Assignee
Biomunex Pharmaceuticals
Date Filed
March 27, 2017
Date of Patent
November 22, 2022
Patent Applicant
Biomunex Pharmaceuticals
Patent Application Number
16088181
Patent Citations
US Patent 10815310 Multispecific antigen binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-kappa domains
US Patent 10633456 Vista antigen-binding molecules
US Patent 10662241 HER3 antigen-binding molecules
US Patent 11046776 Multivalent and multiepitopic antibodies having agonistic activity and methods of use
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11505616
Patent Primary Examiner
Jessica H Roark
CPC Code
C07K 2317/31
C07K 2317/732
C07K 16/2896
C07K 2317/92
C07K 2317/734
C07K 16/2827
Find more entities like US Patent 11505616 Binding molecules to CD38 and PD-L1
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE